throbber
2/8/2018 What does an emerging technology pioneer in medtech look like?
`
`wicNU SLAFCH
`- Health and In1ouch . ) detection via fithess
`Health ' trackers
`
`HEALTHIT
`
`11 health companies make the World Economic
`Group tech pioneer list
`
`By STEPHANIE BAUM
`
`@ Post a comment/ Aug 28, 2013 at 8:46 AM
`
`54
`
`SHARES
`
`Nearly one-third of the 36 emerging technology pioneers chosen by the World
`Economic Forum this year have implications for the life sciences and health IT
`space. They represent robotics, noninvasive prenatal testing, using edible
`
`identifiers to guard against counterfeit drugs and an anti-smoking vaccine.
`
`Since 2000, the World Economic Forum has identified companies based on their
`potential to make a global impact with the groundbreaking technology they’ve
`
`developed. Here are 11 of the companies.
`
`Metabolic enzymes: Agios Pharmaceuticals has determined that some cancer
`cells need to feed an enzyme addiction. So if you can figure out a way to block the
`enzyme you can Kill the cancer’s nutrient supply and avoid affecting the other
`cells. It sees opportunity for up to 100 metabolic enzymes on which various
`cancers depend for nutrients but is developing treatments for eight. It’s also
`looking at genetic diseases that prevent the body from being able to produce a
`specific enzyme from birth — “inborn errors of metabolism.” Most show up in
`early childhood, and have with no treatment. They can be fatal or severely
`
`compromise quality of life.
`
`Harnessing nanotechnology: BIND Therapeutics has developed a drug
`delivery system using nanoparticles to transport therapeutics to fight cancer
`
`without weakening the rest of the body with the toxic treatments. Its lead product
`FOUNDATION EXHIBIT 2040
`
`GUARDANT V. FOUNDATION,,
`IPR 2017-01170
`
`https://medcitynews.com/2013/08/what-does-a-technology-pioneer-in-medtech-look-1 ke-here-are-11/
`
`
`
`
`
`
`
`
`2/8/2018
`
`What does an emerging technology pioneer in medtech look like?
`
`Advertisement A nonprofit medical device
`
`developer: D-Rev: Design
`Revolution’s client base includes people in developing countries. The company
`develops medical devices such as prosthetic knees made with injection molded
`plastic at one-tenth of the cost of, say, a titanium equivalent. Although it does not
`donate its products it sells them for a few dollars apiece. It uses grants for
`research and development. It’s also developing a mass-produced version of the
`plastic knee along with other products. Given the current debate over medical
`costs, the company could make an interesting contribution on potential ways to
`
`reduce costs without jeopardizing patient safety.
`
`Gene therapy — a lesson from HIV: bluebird Bio has developed an
`innovative approach to gene therapy to treat genetic disorders such as childhood
`cerebral adrenoleukodystrophy, a rare and often fatal neurological disorder
`affecting young boys; and beta-thalassemia major and severe sickle cell disease.
`Its treatment approach is inspired by HIV, a lentivirus which can deposit viral
`RNA into the DNA of the host cell. Its technology involves transferring functional
`genes into the patient’s stem cells, which can transform into several different
`types of cells. It’s also collaborating with Celgene and Baylor University to modify
`
`patient’s T cells — a type of white blood cell — to combat cancer.
`
`Noninvasive prenatal testing: Natera appears to have surmounted the
`problem of how to perform prenatal tests to identify chromosomal abnormalities
`accurately and reduce the risk posed to the mother and their unborn child. Its
`Panorama blood test analyses the mother’s blood, which contains fragments of
`free-floating foetal DNA. Its accuracy claims to be comparable to amniocentesis
`and chorionic villus sampling. It uses data from the Human Genome Project to
`calculate the statistical probability that the sample represents a chromosomal
`disorder. The company also offers counseling to help clinicians and parents
`
`interpret the test results.
`
`Personalized cancer treatmment: Foundation Medicine launched a diagnostic
`
`test in June last year that can assess the best course of treatment across 236
`
`https://medcitynews.com/2013/08/what-does-a-technology-pioneer-in-medtech-look-1 ke-here-are-11/ 2/9
`
`
`
`
`
`
`
`
`2/8/2018
`
`What does an emerging technology pioneer in medtech look like?
`
`therapies in the pipeline. Although Foundation has focused on solid tumors, a
`diagnostic test to assess treatment options for blood-based cancers is under
`
`development and expected to reach the market next year.
`
`Crowdsourced answers to big data questions: If you or your company have
`big data questions, Kaggle has a way of generating big data answers through a
`global pool of 100,000 data experts. According to a description of the
`
`company, businesses can either offer cash prizes to members of Kaggle’s
`community who can improve on their existing formulas to extract more value
`from their data sets. A couple of Big Pharma companies — Merck and Boehringer
`Ingelheim — have tapped their resources to get answers to predictive analytics
`questions, such as gauging demand for particular drugs across a wide geographic
`
`base. Participation can also be restricted when data is sensitive.
`
`Restoring vision: Second Sight Medical Products has developed a way to help
`partially restore vision to some patients with retinal degeneration. The procedure
`involves inserting its implant into the retina. The patient wears glasses that
`
`contain a camera. A small computer, on a belt, processes signals from the camera,
`
`and an antenna on the side of the glasses transmits them wirelessly to the implant.
`
`The implant sends electrical impulses to the brain, causing the patient to perceive
`patterns of light. Recipients have been able to follow sidewalks and identify
`doorways and read large print text. It is being developed further with the hope of
`improving the range of abilities restored to users and creating a similar solution
`
`for macular degeneration.
`
`A vaccine for nicotine addiction: A biotechnology company Selecta
`Biosciences is using synthetic nanoparticles to improve the immune system’s
`response. A vaccine against nicotine addiction is the company’s lead product and
`is in the midst of clinical trials. The idea is that by inducing antibodies to trap
`nicotine before it can trigger addiction, it can eliminate cravings. It’s also in the
`early stages of other applications including malaria and cancer. But it sees scope
`for additional areas such as allergies and autoimmune diseases such as type 1
`diabetes.
`
`https://medcitynews.com/2013/08/what-does-a-technology-pioneer-in-medtech-look-1 ke-here-are-11/
`
`3/9
`
`
`
`
`
`
`
`
`2/8/2018
`
`What does an emerging technology pioneer in medtech look like?
`
`similar to humans, in three areas — force, vibration and temperature. The
`
`company also sees scope for surgical applications as well as other areas.
`
`Spotting counterfeits: Counterfeit drugs are a growing concern in the
`healthcare industry. Although there are parts of the U.S. where this has been a
`problem, such as Florida, it is an ongoing issue for developing countries.
`Pharmaceutical companies that want to protect their brand and the patient
`population that uses their medication are working with businesses like TrueTag
`Technologies to make it easier to separate legitimate and fake versions of their
`products. The identifiers, which can be scanned with a handheld device, are made
`of silica and embedded in pills. The substance has been approved by the FDA and
`is safe to eat. Nanotechnology is used to embed a unique code, similar to a bar
`code, into a tag that is smaller than the width of a human hair. These codes are
`linked to a database that adds a time-related dimension of encryption, making the
`tags practically impossible to counterfeit, according to a description of the
`
`technology.
`
`[Photo credit: the concept of education from BigStock Photos]
`
`MedCity Join us for MedCity INVEST May 1-2, 2018, the premier
`
`‘ b national healthcare investing conference. INVEST
`\ , unites over 300 active investors with corporate
`MAY 1-2, 2018 *« CHICAGO business development executives to facilitate
`
`National Healthcare Investing Event jyestment opportunities with the most promising
`
`healthcare startups. Register now »
`
`4 y f G+ in =
`
`SHARES
`
`TOPICS
`
`https://medcitynews.com/2013/08/what-does-a-technology-pioneer-in-medtech-look-1 ke-here-are-11/
`
`4/9
`
`
`
`
`
`
`
`
`2/8/2018
`
`What does an emerging technology pioneer in medtech look like?
`
`—ADVERTISEMENT—
`
`Your email address
`
`WE RECOMMEND
`
`What does an emerging technology pioneer
`in medtech look like?
`
`MedCity News
`
`8 technologies that will transform healthcare
`in 2017 and beyond
`
`MedCity News
`
`CertiRx goes into medications to show how
`to spot counterfeit drugs
`MedCity News
`
`Big data meets genomic profiling to improve
`clinical trials for cancer drugs - MedCity
`News
`
`MedCity News
`
`Top 5 digital health deals in July offer insight
`into hot investment targets
`MedCity News
`
`Drug shortage buster: Mustard Tree aims
`to knock out shortages at the root
`MedCity News
`
`Chanel? Vuitton? Avastin?
`
`GenomeWeb
`
`Genetic Testing Firms Tout Underlying
`Bioinformatics Capabilities as Key
`Business Component
`
`GenomeWeb
`
`Ortho Adopts Startup Culture with Intense
`Dx Focus After Spin Off from J&J
`
`360Dx
`
`Sepsis Diagnostics Year in Review: A
`Highly Competitive Market Emerges
`360Dx
`
`Powered by
`
`https://medcitynews.com/2013/08/what-does-a-technology-pioneer-in-medtech-look-1 ke-here-are-11/ 5/9
`
`
`
`
`
`
`
`
`2/8/2018 What does an emerging technology pioneer in medtech look like?
`
`) Recommend 2 Share
`
`' Start the discussion...
`i
`
`LOG IN WITH OR SIGN UP WITH Disaus (2)
`
`Name
`
`Be the first to comment.
`
`B4 subscribe ) Add Disqus to your siteAdd DisqusAdd @ Privacy
`
`Sort by Best
`
`[<] GOT NEWS? SEND US ATIP
`
`MedCity
`
`INVEST
`
`MAY 1-2, 2018 - CHICAGO
`National Healthcare Investing Event
`
`Join Us at MedCity INVEST 2018
`
`MedCity INVEST is the premier national healthcare investing conference based in the Midwest,
`uniting active investors with corporate business development executives to facilitate investment
`opportunities with the most promising healthcare startups. MedCity INVEST will be held May
`
`1-2, 2018 at the Four Seasons, Chicago. Register Now >>
`
`https://medcitynews.com/2013/08/what-does-a-technology-pioneer-in-medtech-look-1 ke-here-are-11/
`
`
`
`
`
`
`
`
`2/8/2018 What does an emerging technology pioneer in medtech look like?
`
`financial future
`
`Learn how from experts and
`get your pressing questions answered
`
`CrthoNOW
`
`We keep you moving.
`
`PROMOTED
`Orthopedic Urgent Care Franchising is THE Opportunity of 2018
`
`With approximately 9,000 urgent care centers in the United States offering generalized care,
`OrthoNOW is the only franchised care center of its kind in the United States — a unique
`position to gain market share in this highly fragmented industry.
`
`CHRISTINE DURA
`
`MEDCITY >> INBOX
`
`Get the latest industry news first when you subscribe to our daily newsletter.
`
`Your email address
`
`Subscribe
`
`https://medcitynews.com/2013/08/what-does-a-technology-pioneer-in-medtech-look-1 ke-here-are-11/
`
`7/9
`
`
`
`
`
`
`
`
`2/8/2018 What does an emerging technology pioneer in medtech look like?
`
`B ESSENTIALNUTRIENTS
`
`PROMOTED
`
`New study: frequent use of multivitamin/multimineral
`supplements reduces nutrient shortfalls and deficiencies
`
`Up to 9 in 10 Americans fall short in getting required amounts of one or more key nutrients
`from food alone
`
`CAMPAIGN FOR ESSENTIAL NUTRIENTS
`
`OUR SITES
`
`ABOVE
`THE L AW
`
`ABOVE THE LAW BREAKING
`ER IANE
`REDLINE DEFENSE
`
`BREAKING
`
`DEALBREAKER FASHIONISTA
`MedCity News
`
`https://medcitynews.com/2013/08/what-does-a-technology-pioneer-in-medtech-look-1 ke-here-are-11/
`
`HOW
`APPEALING
`
`
`
`
`
`
`
`
`
`2/8/2018 What does an emerging technology pioneer in medtech look like?
`
`https://medcitynews.com/2013/08/what-does-a-technology-pioneer-in-medtech-look-1 ke-here-are-11/ 9/9
`
`
`
`
`
`
`
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket